4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-022473
Chief Executive Officer sold 2,735 shares at $4.67 ($12,767)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Townsend Richard Nolan Chief Executive Officer | 2025-08-18 | Sale | −2,735 | $4.67 | $12,767 | 220,058 | D |
| Open-market sales · 2,735 sh · avg $4.67 · $12,767 | |||||||
Loading xslF345X05/form4-08202025_090813.xml…